Literature DB >> 2863707

Increased plasma levels of immunoreactive beta-endorphin and corticotropin in non-insulin-dependent diabetes.

I Vermes, E Steinmetz, J Schoorl, E A van der Veen, F J Tilders.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 2863707     DOI： 10.1016/s0140-6736(85)92964-2

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  8 in total

Review 1.  Opioid peptides and metabolic regulation.

Authors:  D Giugliano; R Torella; P J Lefèbvre; F D'Onofrio
Journal:  Diabetologia       Date:  1988-01       Impact factor: 10.122

Review 2.  The endocrine system in diabetes mellitus.

Authors:  Hisham Alrefai; Hisham Allababidi; Shiri Levy; Joseph Levy
Journal:  Endocrine       Date:  2002-07       Impact factor: 3.633

Review 3.  The Clash of Two Epidemics: the Relationship Between Opioids and Glucose Metabolism.

Authors:  Laura L Koekkoek; Luna L van der Gun; Mireille J Serlie; Susanne E la Fleur
Journal:  Curr Diab Rep       Date:  2022-05-20       Impact factor: 5.430

Review 4.  Diabetic keratopathy and treatment by modulation of the opioid growth factor (OGF)-OGF receptor (OGFr) axis with naltrexone: a review.

Authors:  Patricia J McLaughlin; Joseph W Sassani; Matthew S Klocek; Ian S Zagon
Journal:  Brain Res Bull       Date:  2009-08-14       Impact factor: 4.077

5.  Plasma beta-endorphin, free fatty acids and blood lipid changes in type 2 (non-insulin dependent) diabetic patients.

Authors:  S B Solerte; M Fioravanti; F Petraglia; F Facchinetti; A L Patti; N Schifino; A R Genazzani; E Ferrari
Journal:  J Endocrinol Invest       Date:  1988-01       Impact factor: 4.256

6.  Elevated fasting plasma cortisol is associated with ischemic heart disease and its risk factors in people with type 2 diabetes: the Edinburgh type 2 diabetes study.

Authors:  Rebecca M Reynolds; Javier Labad; Mark W J Strachan; Anke Braun; F Gerry R Fowkes; Amanda J Lee; Brian M Frier; Jonathan R Seckl; Brian R Walker; Jackie F Price
Journal:  J Clin Endocrinol Metab       Date:  2010-02-03       Impact factor: 5.958

7.  Antihyperglycemic mechanism of metformin occurs via the AMPK/LXRα/POMC pathway.

Authors:  Kumsun Cho; Jae Yong Chung; Sung Kweon Cho; Hyun-Woo Shin; In-Jin Jang; Jong-Wan Park; Kyung-Sang Yu; Joo-Youn Cho
Journal:  Sci Rep       Date:  2015-01-30       Impact factor: 4.379

8.  Effects of caloric restriction and low glycemic index diets associated with metformin on glucose metabolism and cortisol response in overweight/obese subjects: a case series study.

Authors:  Luiz Augusto Casulari; Donatella Dondi; Fabio Celotti; Fábio Vinicius Pires da Silva; Caio Eduardo Gonçalves Reis; Teresa Helena Macedo da Costa
Journal:  Diabetol Metab Syndr       Date:  2015-07-22       Impact factor: 3.320
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.